Outcomes of children with idiopathic steroid resistant nephrotic syndrome: a single centre observational study

Om P Mishra1, Minketan Sidar1, Vineeta V Batra2

  • 1Banaras Hindu University, Institute of Medical Sciences, Department of Pediatrics, Division of Pediatric Nephrology, Varanasi, India.

Insights

Half of children with idiopathic steroid resistant nephrotic syndrome (SRNS) achieved remission. Factors like age, medication, and histology did not impact remission or kidney function survival in this 5-year study.

Area of Science:

  • Pediatric Nephrology
  • Immunology
  • Clinical Medicine

Background:

  • Idiopathic steroid-resistant nephrotic syndrome (SRNS) presents variable outcomes in pediatric populations.
  • Understanding factors influencing remission and kidney function is crucial for managing SRNS.

Purpose of the Study:

  • To determine the cumulative remission rate in children with SRNS.
  • To identify factors affecting remission status, kidney function survival, and medication side effects.

Main Methods:

  • A cohort of 114 pediatric patients with SRNS was analyzed over a 5-year follow-up period.
  • Treatment involved a calcineurin inhibitor-based protocol, prednisolone, and angiotensin-converting enzyme inhibitors.
  • Data collected included age of onset, eGFRcr, histopathology, and adverse events.

Main Results:

  • 57.3% of patients achieved remission (30% complete, 27.3% partial).
  • Kidney function survival was 87.3%, with 12.7% progressing to chronic kidney disease (CKD).
  • Age of onset, calcineurin inhibitor use, and histopathology did not significantly influence remission or kidney function survival.

Conclusions:

  • Approximately half of pediatric SRNS patients achieved remission.
  • Early disease onset, specific medications (cyclosporine/tacrolimus), and histopathology did not predict remission or short-term kidney function outcomes.
  • Further research may explore other therapeutic targets for SRNS.
Abstract

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
16
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
34
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
21
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
71
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
64
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53